Commit To Purchase Pacira Pharmaceuticals At $75, Earn 9.9% Annualized Using Options
December 09, 2014 at 11:38 AM EST
Investors considering a purchase of Pacira Pharmaceuticals Inc. (PCRX) shares, but tentative about paying the going market price of $92.09/share, might benefit from considering selling puts among the alternative strategies at their disposal..